Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 157,614 | 74,932 | 150,456 | 119,456 | 8,532 |
| Marketable Securities | 168,489 | 272,500 | 265,198 | N/A | N/A |
| Receivables | 18,484 | 1,138 | 4,846 | 3,153 | 357 |
| TOTAL | $350,131 | $354,764 | $424,504 | $125,221 | $9,356 |
| Non-Current Assets | |||||
| PPE Net | 31,085 | 26,384 | 3,986 | 1,053 | 399 |
| Investments And Advances | 23,614 | 14,474 | 15,391 | 0 | 0 |
| Intangibles | 39,830 | 35,485 | 37,869 | 0 | 0 |
| Other Non-Current Assets | 468 | 7,504 | 75 | 188 | 125 |
| TOTAL | $94,997 | $83,847 | $57,321 | $1,241 | $524 |
| Total Assets | $445,128 | $438,611 | $481,825 | $126,462 | $9,880 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,150 | 2,206 | 5,086 | 5,030 | 763 |
| Accrued Expenses | 18,499 | 13,374 | 10,934 | 5,758 | 2,028 |
| Other current liabilities | 6,829 | N/A | N/A | N/A | N/A |
| TOTAL | $41,401 | $30,632 | $31,066 | $44,215 | $14,431 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 14,923 | 15,052 | 15,046 | 33,427 | 57 |
| Other Non-Current Liabilities | 1,577 | 5,141 | 3,750 | 989 | 1,983 |
| TOTAL | $166,254 | $180,759 | $189,137 | $3,581 | $1,983 |
| Total Liabilities | $207,655 | $211,391 | $220,203 | $47,796 | $16,414 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,201 | 13,600 | 12,904 | N/A | N/A |
| Common Shares | 8 | 7 | 6 | N/A | N/A |
| Retained earnings | -283,863 | -192,000 | -100,852 | -61,643 | -44,629 |
| Other shareholders' equity | 1,893 | -1,684 | -339 | 139,963 | 32,224 |
| TOTAL | $237,473 | $227,220 | $261,622 | $78,666 | $-6,534 |
| Total Liabilities And Equity | $445,128 | $438,611 | $481,825 | $126,462 | $9,880 |